Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Equine Healthcare Market

Equine Healthcare Market Share

Report ID: GMI7396
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Equine Healthcare Market Share

The industry comprises intense competition, with key players and industry stakeholders actively implementing strategic measures. These include expanding their product portfolios, introducing upgraded products, forming partnerships, extending their presence to new regions, and engaging in mergers and acquisitions. Zoetis, Vetoquinol and Boehringer account for significant market share in the overall industry.

Market players operating in the market is as mentioned below:

Zoetis
Boehringer Ingelheim International GmbH
MERCK & CO., INC.
Vetoquinol S.A.
Ceva
Hallmarq Veterinary Imaging
SOUND
ESAOTE SPA
Dechra Pharmaceuticals PLC
IDEXX Laboratories, Inc.
Sante Animale

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for equine healthcare was around USD 1.7 billion in 2022 and is expected to reach USD 3.2 billion by 2032.

The veterinary hospital pharmacies segment accounted for USD 798.3 million in 2022 and will grow significantly through 2032 due to their central role in providing essential healthcare services and products.

North America market is expected to record 6.2% CAGR from 2023 to 2032 owing to the increasing presence of horse farms and the annual horse racing events across the region.

Zoetis, Boehringer Ingelheim International GmbH, MERCK & CO., INC., Vetoquinol S.A., Ceva, Hallmarq Veterinary Imaging, SOUND, ESAOTE SPA, Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., and Sante Animale.